| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 7 | 12/10/2024 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $402,713 ) |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 7 | 5/16/2024 | NON-COMPETING CONTINUATION | $40,271 |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 7 | 12/14/2023 | NON-COMPETING CONTINUATION | $362,442 |
|
 | Issue Date FY: 2023 ( Subtotal = $86,051 ) |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 6 | 12/23/2022 | NON-COMPETING CONTINUATION | $86,051 |
|
 | Issue Date FY: 2022 ( Subtotal = $488,765 ) |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 005 | 5 | 8/29/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $346,654 |
| 2022 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 004 | 4 | 8/29/2022 | NON-COMPETING CONTINUATION | -$92,716 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 002 | 5 | 5/27/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $396,049 |
| 2022 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 4 | 5/27/2022 | NON-COMPETING CONTINUATION | -$396,048 |
| 2022 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 4 | 12/14/2021 | NON-COMPETING CONTINUATION | $488,764 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 003 | 3 | 8/29/2022 | NON-COMPETING CONTINUATION | -$253,938 |
|
 | Issue Date FY: 2021 ( Subtotal = $488,764 ) |
| 2021 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 3 | 11/19/2020 | NON-COMPETING CONTINUATION | $488,764 |
|
 | Issue Date FY: 2020 ( Subtotal = $480,355 ) |
| 2020 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 2 | 11/21/2019 | NON-COMPETING CONTINUATION | $480,355 |
|
 | Issue Date FY: 2019 ( Subtotal = $418,755 ) |
| 2019 | 2019 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 1 | 12/6/2018 | NEW | $418,755 |
|
|